+ All Categories

Home > Documents > Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J....

Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J....

Date post:	06-Jan-2018
Category:	Documents
Upload:	leonard-oconnor
View:	216 times
Download:	0 times

Download Report this document

Share this document with a friend

Description:

Figure 2 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2010 Elsevier Inc. Terms and Conditions Terms and Conditions

Embed Size (px):

9

Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne, David D. Goldenberg, Scott R. Vandenberg, Kim N. Nguyen, Stanislava Yakovenko, Jennifer Ayers-Ringler, Akiko Nishiyama, William B. Stallcup, Mitchel S. Berger, Gabriele Bergers, Tracy R. McKnight, Steven A. Goldman, William A. Weiss Cancer Cell Volume 18, Issue 6, Pages 669-682 (December 2010) DOI: 10.1016/j.ccr.2010.10.033 Copyright © 2010 Elsevier Inc. Terms and Conditions

Transcript

Page 1: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Non-Stem Cell Origin for Oligodendroglioma

Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne, David D. Goldenberg, Scott R. Vandenberg, Kim N. Nguyen, Stanislava Yakovenko, Jennifer Ayers-Ringler, Akiko Nishiyama, William B. Stallcup, Mitchel S. Berger,

Gabriele Bergers, Tracy R. McKnight, Steven A. Goldman, William A. Weiss

Cancer Cell Volume 18, Issue 6, Pages 669-682 (December 2010)

DOI: 10.1016/j.ccr.2010.10.033

Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 2: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 1

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 3: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 2

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 4: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 3

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 5: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 4

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 6: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 5

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 7: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 6

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 8: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 7

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Page 9: Non-Stem Cell Origin for Oligodendroglioma Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne,

Figure 8

Cancer Cell 2010 18, 669-682DOI: (10.1016/j.ccr.2010.10.033) Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Recommended

Cellular/Molecular Oligodendrocyte/Type ... · 2010;Liuetal.,2011;Friedmann-Morvinskietal.,2012;Ghaziet al., 2012; Swartling et al., 2012). Some of these studies further suggest an

The Mergers & Acquisitions Review - huntonak.com · MAkeS & PARTneRS LAW fiRM MAnnheiMeR SWARTLinG AdvokATByR ...

Glioma: state of the art approach€¦ · Anaplastic glioma Reported survival after RT/chemo Oligodendroglioma, IDHmut & 1p/19q codeleted > 14 years Astrocytoma, IDH mutated 7 - 8

Climber’s Guide to Devils Lake, G P Librarianaac-publications.s3.amazonaws.com/documents/aaj/1978/PDF/...Swartling have completed revisions to the Climber's Guide to Devils Lake,

jblication ofthe International Association Technology … · 2013-01-31 · Oligodendroglioma Classification using Higuchi DimensionAnalysis HerbertF. Jelinek, HelmutAhammer, SladeMatthews,

Classification of spontaneous brain tumors in ratsnibs.lin.gr.jp/pdf/doc004.pdf · 2012. 3. 22. · Astrocytoma Oligodendroglioma Mixed glioma (oligo-astrocytoma) Anaplastic glioma

Cybersecurity mannheimer swartling Law Overview april 2017...electronic means (“cybercrime”) and acts for which there is a clear corresponding criminal act when committed physically

CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL ... · anaplastic oligodendroglioma) and grade, extended initial surgical resection, and certain molecular genetic alterations (isocitrate

Oligodendroglioma with 1p/19q co-deletion: What is (are ... · Oligodendroglioma with 1p/19q co-deletion: What is ... Grade III Anaplastic Astro AnaplasticOligoastro Anaplastic Oligo

Sweden - Mannheimer Swartling · PLC Country Q&A Sweden Life Sciences 2009/10 Country Q&A Sweden.

Cartel Regulation - Mannheimer Swartling€¦ · notifications; the cartel and merger unit (T1) and the abuse and verti-cal restraints unit (T2). In addition, there is the department

By: Nour-Eldin A Nour-Eldin. Female Patient, 35 years, recurrent attacks of Headache. Non Contrast CT DD: 1.Oligodendroglioma 2.Tuberculoma 3.Cavernoma.

annonsprislista 2011egmont-media.s3-website-eu-west-1.amazonaws.com/ams/... · 2014. 6. 25. · Annonsbokning: Swartling & Bergström Media AB Erik Bergström och Robert Swartling

Case Report Malignant Trigeminal Nerve Sheath Tumor and ...(including glioblastoma) Suh et al. [ ] Suprasellar chordoid glioma and Rathke scle cyst Johnson et al. [ ] Oligodendroglioma

Antagonistic Modulation of Gliomagenesis by Pax6 and Olig2 in PDGF-Induced Oligodendroglioma

Exercises - EIT, Electrical and Information Technology · 2020-03-05 · Exercises Digital Signal Processing Exercise Problems with Solutions Mikael Swartling, Nedelko Grbic, and

GLOBAL COMPETITION REVIEW Merger Control - Checklist.pdf · LEX Mannheimer Swartling ... Merger Control 2014 Published by Law Business Research Ltd ... bunal (the Tribunal) for a

High grade gliomas diagnosis management and controversiesaiimsnets.org/NeurosurgeryEducation...Glioma Grading Astrocytoma Oligodendroglioma Mdi i l mixed • Grade II: 5 yr (3-10y)